Dynavax Technologies
DVAX
#5033
Rank
C$2.55 B
Marketcap
C$21.78
Share price
0.00%
Change (1 day)
13.60%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -C$51.98 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$52.89 Million, an increase over its 2023 earnings that were of C$3.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$51.98 Million-198.25%
2024 C$52.89 M1475.31%
2023 C$3.35 M-99.2%
2022 C$0.42 B238.78%
2021 C$0.12 B-257.89%
2020 -C$78.94 Million-58.58%
2019 -C$0.2 Billion-9.32%
2018 -C$0.22 Billion60.44%
2017 -C$0.14 Billion-15.8%
2016 -C$0.16 Billion4.22%
2015 -C$0.15 Billion16.54%
2014 -C$0.13 Billion37.09%
2013 -C$93.42 Million
2010 -C$66.87 Million214.85%
2009 -C$21.24 Million-37.33%
2008 -C$33.89 Million-66.07%
2007 -C$99.89 Million16.92%
2006 -C$85.43 Million170.36%
2005 -C$31.6 Million33.39%
2004 -C$23.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.88 B-31,352.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.76 B-26,914.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.28 B-4,889.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.76 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.47 B-38,910.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.60 B-43,371.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$14.06 B-29,642.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$29.03 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.19 B-6,801.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel